Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Annals of Hematology
Published in: Annals of Hematology 4/2021

01-04-2021 | Lymphoma | Letter to the Editor

Single-drug vinorelbine as a salvage re-induction regimen for 4 consecutive pediatric patients with relapsed anaplastic large-cell lymphoma in a single children’s institution

Authors: Qing Yuan, Qiao He, Qiang Mi, Min-Zhi Yin, Ya-Li Han, Yi-Jin Gao

Published in: Annals of Hematology | Issue 4/2021

Login to get access

Excerpt

Dear Editor, …
Literature
1.
Brugières L, Pacquement H, Le Deley MC et al (2009) Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology. J Clin Oncol 27:5056–5061CrossRef
2.
Kuttesch JF, Krailo MD, Madden T et al (2009) Phase II evaluation of intravenous vinorelbine (Navelbine) in recurrent or refractory pediatric malignancies. A Children’s oncology group study. Pediatr Blood Cancer 53:590–593CrossRef
3.
Subspecialty Group of Hematology, the Society of Pediatrics, Chinese Medical Association, Pediatric Oncology Committee, Chinese Anticancer Association, Editorial Board of Chinese Journal of Pediatrics (2011) Recommendation for pediatric non-Hodgkin’s lymphoma [in Chinese]. Zhonghua Er Ke Za Zhi 49:186–192
4.
Woessmann W, Zimmermann M, Lenhard M, Burkhardt B, Rossig C, Kremens B, Lang P, Attarbaschi A, Mann G, Oschlies I, Klapper W, Reiter A (2011) Relapsed or refractory anaplastic large-cell lymphoma in children and adolescents after Berlin-Frankfurt-muenster (BFM)-type first-line therapy: a BFM-group study. J Clin Oncol 29:3065–3071CrossRef
Metadata
Title
Single-drug vinorelbine as a salvage re-induction regimen for 4 consecutive pediatric patients with relapsed anaplastic large-cell lymphoma in a single children’s institution
Authors
Qing Yuan
Qiao He
Qiang Mi
Min-Zhi Yin
Ya-Li Han
Yi-Jin Gao
Publication date
01-04-2021
Publisher
Springer Berlin Heidelberg
Published in
Annals of Hematology / Issue 4/2021
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-020-04175-3

Other articles of this Issue 4/2021

Annals of Hematology 4/2021 Go to the issue

Original Article

Advanced Hodgkin lymphoma in the East of England: a 10-year comparative analysis of outcomes for real-world patients treated with ABVD or escalated-BEACOPP, aged less than 60 years, compared with 5-year extended follow-up from the RATHL trial

Original Article

Ambulatory high-dose methotrexate administration as central nervous system prophylaxis in patients with aggressive lymphoma

Original Article

The prognostic value of the Fibrinogen-Albumin Ratio Index in patients with myelodysplastic syndrome and acute myeloid leukemia with myelodysplasia-related changes treated with azacitidine

Original Article

Daratumumab in multiple myeloma: experience of the multiple myeloma GIMEMA Lazio group

Original Article

Anti-CD19 CAR-T cell therapy bridge to HSCT decreases the relapse rate and improves the long-term survival of R/R B-ALL patients: a systematic review and meta-analysis

Original Article

Effectiveness and safety of tacrolimus with or without eltrombopag, as a part of immunosuppressive treatment of aplastic anemia in adults: a retrospective case series

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits